Combination treatment of persistent COVID-19 in immunocompromised patients with remdesivir, nirmaltrevir/ritonavir and tixegavimab/cilgavimab https://www.medrxiv.org/content/10.1101/2023.04.07.23288144
Combination treatment of persistent COVID-19 in immunocompromised patients with remdesivir, nirmaltrevir/ritonavir and tixegavimab/cilgavimab https://www.medrxiv.org/content/10.1101/2023.04.07.23288144